Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Panitumumab can cause excessive ear hair growth.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Targeted cancer therapies often cause serious skin problems that need careful management.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

The nude gene causes skin cell overgrowth and improper development, leading to hair and urinary issues.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Multiphoton microscopy is a promising tool for detailed skin imaging and could improve patient care if its challenges are addressed.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Keratoacanthoma comes from hair follicle cells.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Laminin-511 may contribute to psoriasis by affecting skin cell growth and survival.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

A patient grew extra hair on their ears after treatment for testicular cancer, possibly due to hormonal changes or genetics.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

p14ARF and p16Ink4a cause hair follicle stem cell aging and dysfunction.

Epidermal Growth Factor helps hair follicle cells grow and move by activating a specific cell signaling pathway.

Skin reactions from cancer treatments might predict how well the treatments work.

Researchers found WNT10A to be a key gene in developing goat hair follicles.